The pathology of many neurodegenerative diseases is characterized by the accumulation of misfolded and aggregated proteins in various cell types and regional substructures throughout the central and peripheral nervous systems. The accumulation of these aggregated proteins signals dysfunction of cellular protein homeostatic mechanisms such as the ubiquitin/proteasome system, autophagy, and the chaperone network. Although there are several published studies in which transcriptional profiling has been used to examine gene expression in various tissues, including tissues of neurodegenerative disease models, there has not been a report that focuses exclusively on expression of the chaperone network. In the present study, we used the Allen Brain Atlas online database to analyze chaperone expression levels. This database utilizes a quantitative in situ hybridization approach and provides data on 270 chaperone genes within many substructures of the adult mouse brain. We determined that 256 of these chaperone genes are expressed at some level. Surprisingly, relatively few genes, only 30, showed significant variations in levels of mRNA across different substructures of the brain. The greatest degree of variability was exhibited by genes of the DnaJ co-chaperone, Tetratricopeptide repeat, and the HSPH families. Our analysis provides a valuable resource towards determining how variations in chaperone gene expression may modulate the vulnerability of specific neuronal populations of mammalian brain.
Citation: Tebbenkamp ATN, Borchelt DR (2010) Analysis of Chaperone mRNA Expression in the Adult Mouse Brain by Meta Analysis of the Allen Brain Atlas. PLoS ONE 5(10): e13675. doi:10.1371/journal.pone.0013675
Editor: David C. Rubinsztein, University of Cambridge, United Kingdom
Received: April 15, 2010; Accepted: October 4, 2010; Published: October 28, 2010
Copyright: © 2010 Tebbenkamp, Borchelt. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Huntington's Disease Society of America Coalition for the Cure (www.hdsa.org) and the CHDI Foundation (www.highqfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
A common feature of the neurodegenerative diseases is the accumulation of misfolded and aggregated proteins in pathologic inclusion bodies in specific populations of neurons and, or, astroglia (for review see ). Recent studies in several model systems have suggested that accumulation of the pathologic protein aggregates imposes a burden on the protein homeostatic system , which includes the ubiqiutin/proteasome system, autophagic clearance systems, protein synthesis, and the chaperone network. Each of these systems functions in equilibrium to maintain the integrity of the proteome.
Among these systems, the protein chaperone network, which includes the heat shock proteins (HSPs), has received a significant amount of attention as a potential protective factor in neurodegenerative disease –. Chaperones can serve a variety of functions such as facilitating the folding of nascent proteins, refolding misfolded proteins, targeting proteins for degradation, preventing the aggregation of misfolded proteins, and transporting proteins across organelle membranes. Organized by molecular size and function, the families consist of, and are organized herein as, HSP70/HSPA, HSP40/DnaJ, HSP90/HSPC, Tetratricopeptide repeat domain (TPR) (or HSP 90 co-chaperones), small HSP (sHSP)/HSPB, HSP100 (which includes AAA+ ATPase proteins)/HSPH, HSP60 (chaperonins)/HSPD and HSPE, and Heat shock factors (HSF). Nomenclature used throughout this article follows that of the Cell Stress Society International, whenever possible . Constituents of each family function via multiple mechanisms to regulate protein folding or mitigate the accumulation of misfolded proteins. The HSPAs and DnaJs work cooperatively in protein folding, utilizing ATP in the binding and release of substrates, with DnaJs stabilizing interactions of HSPAs with client proteins . Similarly, HSPCs and their co-chaperones, identified by the presence of a TPR domain, coordinate client binding and ATP hydrolysis. The HSPBs, including the crystallins, mitigate protein aggregation by binding to exposed hydrophobic domains in misfolded clients to maintain solubility and assist in re-folding , . The HSPH family and AAA+ ATPase proteins, impart a wide range of functions including proteins capable of exhibiting chaperone activity similar to the chaperonin family . Chaperonins, with the guidance of Prefoldins, fold nascent polypeptides in a hetero-oligomeric chaperonin complex, which can encapsulate proteins that range in size up to 100 kDa . The HSFs are upstream regulators of inducible HSP expression (for review see ).
One of the most poorly understood aspects of neurodegenerative disease involves the basis of cell and tissue vulnerability. In most of the inherited forms of neurodegeneration, the protein harboring the disease-causing mutation is ubiquitously or widely expressed, and yet often the pathology disproportionately affects specific populations of neurons. In diseases that are primarily disorders of the brain, specific substructures of the brain are either more vulnerable to accumulate misfolded proteotoxins, or in settings of widespread proteinopathy, specific substructures are more prone to degeneration. For example, in Alzheimer's disease inclusion bodies formed by Tau protein appear first in the entorhinal cortex before the pathology appears throughout the brain . By contrast, Huntington's disease is characterized by severe degeneration of the caudate/putamen and cortex, with minimal degeneration of the cerebellum, despite near uniform expression of the disease protein, huntingtin, throughout the brain and widespread distribution of nuclear inclusion pathology , . One potential mechanism to explain cell and tissue vulnerability could be related to diversity in the expression of protein chaperones across different neuronal populations and different tissues.
The transcriptional regulation of the HSPs is complex with examples of both constitutive and inducible regulatory mechanisms (for review see ). Previous studies have performed gene expression analysis of normal and diseased mouse CNS tissue which provide some clues to regional chaperone expression –. However, cross-experimental conclusions regarding expression levels are difficult to draw due to different sample preparations, controls, etc. Moreover, most of these studies have focused on changes in gene expression due to a disease-related insult. In the present study, we focus on characterization of the pattern of chaperone expression in specific substructures of the normal adult murine brain. Our aim was to establish a baseline expression of the chaperone network to provide a framework to explore the basis for neural vulnerability. To do this, we mined the on-line database of the Allen Brain Atlas (www.brain-map.org; ) as the source for all expression data. We then compiled the data on HSPAs, HSPCs, DnaJs and TPR domain proteins (co-chaperones to HSPAs and HSPCs, respectively), HSPBs, HSPHs, chaperonins, and HSFs and compared expression levels, as measured by in situ hybridization, across multiple structures of the brain. Our analysis reveals relatively little diversity in the expression patterns of chaperones, chaperonins, and the HSFs. By contrast, although less than one might have expected, the expression patterns of DnaJs and TPR domain proteins and the AAA+ ATPases showed greater diversity. Overall, this study provides a framework to investigate the extent to which diversity in the expression patterns of the heat shock proteins plays a role in the selective vulnerability of neuronal populations to specific misfolded proteins.
The goal of the Allen Brain Atlas is to provide a “genome-wide map of gene expression in the mouse brain”. To accomplish this goal, coronal or sagittal tissue sections (fresh-frozen and unfixed, 25 µm thick) were probed by in situ hybridization (ISH) using sections spaced at intervals of 200 µm throughout the brain of 8-week old male C57BL/6J mice. Gene expression was visualized by ISH, using anti-sense probes generated with digoxigenin-labeled nucleotides. Bound probes were later visualized by adding the alkaline phosphatase substrate 5-bromo-4-chloro-3-indolyl phosphate (BCIP) then nitroblue tetrazolium (NBT). An in depth description of the high-throughput procedures and data acquisition can be found on the website (www.brain-map.org). The expression of over 20,000 genes, as of 2006, has been characterized. Unique gene entries were compiled first from the RefSeq database, followed by unique entries from TIGR and Celera databases and from the Riken FANTOM3 database. For each gene with a successful probe, raw images are accompanied by data showing quantified expression levels and densities. From this data we generated tables that provide a summary of HSP expression data.
To generate our database of heat shock proteins, we searched the NCBI database Clusters of euKaryotic Orthologous Groups (KOG) for HSPs and related homologues that are found in the human genome. Human protein accession numbers were used in the Basic Local Alignment Search Tool (BLAST) to find corresponding mouse HSPs. This list was cross-referenced with the Allen Brain Atlas database to ensure all HSPs were accounted for, including any that may not have been found from the initial KOG search. In other cases, namely the TPR domain proteins, the Picard lab website (http://www.picard.ch/downloads/downloads.htm), primary literature, and the NCBI Entrez Gene database was searched for empirical data for interactions or classifying motifs. The TPR family contains hundreds  of members, some of which may have no role in protein folding. Thus we focused on examining expression levels for the TPR family proteins with known function in protein folding.
Once we had assembled a gene list, we searched the Allen Brain Atlas database for expression data from the adult mouse brain. The data sets were organized by gene family as previously outlined. Of the 288 genes we identified in the mouse genome as constituents of the protein homeostasis network, expression data for 270 were found in the Allen Brain Atlas (Table 1 and Table S1). For some of the genes (e.g. Hsbp8) the database included 2 probe sets; in those cases both data sets were used in this meta-analysis. The ABA provides expression values from both coronal and sagittal sections, but although the values obtained from these different planes of section are similar in magnitude, they are not always identical. For consistency, we analyzed only data from sagittal sections. Abbreviations of the brain regions that were analyzed are: Forebrain: OFL, olfactory bulb; CTX, cerebral cortex; HIP, hippocampal region; HPF, hippocampal formation; RHP, retrohippocampal region; Basal Forebrain: LSX, lateral septal complex; STRv, striatum ventral region; STR, striatum; STRd, striatum dorsal region; PAL, pallidum; sAMY, striatum-like amygdalar nucleus; Midbrain: HY, hypothalamus; TH, thalamus; MB, midbrain; Hindbrain: P, pons; MY, medulla; CB, cerebellum.
Four C57BL/6J male mice at eight weeks of age were perfused with cold phosphate-buffered saline (PBS) followed by dissection on ice into eight brain regions: olfactory bulb (OLF), cortex (CTX), hippocampus (HIP), striatum (STR), thalamus and hypothalamus (TH/HY), midbrain (MB), pons and medulla (PN/MD), and cerebellum (CB). Brain tissue was homogenized by sonication in 10∶1 weight:volume Tris-buffered saline (20 mM Tris-HCl, 130 mM NaCl, pH 7.4). Homogenates were centrifuged at 3000× g for 5 minutes, and the supernatant was then mixed with sample buffer (60 mM Tris-HCl, 2% SDS, 0.01% bromophenol blue, 5% beta-mercaptoethanol). The mixed homogenates were sonicated again before boiling then loading onto 4–20% Tris-glycine polyacrylamide gels (Invitrogen, Carlsbad, CA) for SDS-PAGE. Following gel electrophoresis, proteins were transferred to nitrocellulose membranes, which were then incubated with antibodies against chaperones: DnaJb1, DnaJb2, and Tomm70a (Abcam, Cambridge, MA). The Gapdh antibody was a generous gift from Gerry Shaw (University of Florida). Western blots were imaged and bands quantified with a Fuji imaging system (FUJIFILM Life Science, Stamford, CT). Data was analyzed by a one-way ANOVA followed by a post-hoc Tukey test to determine statistical differences (GraphPad Prism 5.0, San Diego, CA).
Results and Discussion
The expression data in the ABA database are assigned numerical values for strength of signal (relative to a positive control, dopamine receptor, Drd1a) with values ranging from 0 to 100. To make expression level comparisons between different regions of the brain, we grouped values in quintiles from highest to lowest expression and assigned each quintile a color code that is similar to the code used in heat maps: 81–100 (red), 61–80 (yellow), 41–60 (green), 21–40 (blue), >0–20 (gray), and 0 (white). Using the color codes, we generated a visually interactive representation of the expression levels of these genes across multiple brain regions.
Expression data for a total of 270 chaperone genes was identified in the Allen Brain Atlas database. The 270 genes examined include 14 chaperones (HSPA and HSPC), 139 co-chaperones (DnaJ and TPR domain), 94 accessory chaperones (HSPB, HSPH, and others), 18 chaperonins (including HSPD and HSPE), and 5 HSFs (Table 1). Nearly all of these genes, 256, were expressed at some level in brain; 13 chaperones, 136 co-chaperones, 86 accessory chaperones, 16 chaperonins, and 5 HSF genes. Of these 256 expressed genes, 145 show some level of variation, meaning that the level of expression ranks in different quintiles in at least one region of the brain (Table 1). It is important to note, however, that a difference of only one quintile ranking could be very small (possibly far less than 20 expression units). Thus, we considered a difference of only one quintile ranking as essentially equivalent. When we determined how many genes differ in expression level across different regions of the brain by ≥2 quintiles in ≥2 regions of the brain, only 30 (∼10%) of the genes qualify as showing variability in expression level across different regions of the brain (Table 1).
Notably, relatively few genes of the total chaperone network are ubiquitously expressed at high levels (Table 2, Table S2). By contrast, 95 genes showed ubiquitously low or no expression (Table 2, Table S2). Some of the 15 genes that are not expressed are known to be stress/heat inducible; however, it is sill noteworthy that approximately one-third of the genes in the chaperone network are expressed at relatively low levels in brain. Below, we summarize the findings of our analysis, first according to HSP class then by brain region and expression levels. Within each color-coded figure, brain regions are organized in a general rostral to caudal fashion. Regions were grouped into forebrain, basal forebrain, midbrain, and hindbrain. With regard to cell-type specificity, the ABA does not give the necessary resolution or markers indicating cell type for each probe. In general, we could expect that large cell bodies of neurons would be the source of most of the mRNA hybridization signal. Although the clients and targets of functionality for the vast majority of these chaperones in brain are unknown, we provide information regarding function whenever possible.
The major chaperones to respond to cell stress are the HSPAs. Four of these are highly expressed throughout the brain (Figure 1). However, half of these ten genes are expressed at or below the 20th percentile (1–20%). It is important to note that some of these poorly expressed genes include genes that are heat/stress inducible, namely Hspa1a the classic HSP70. Mice nullizygous for Hspa1a exhibit a deficit in protection against cell death after cerebral ischemia , TNF-α toxicity , or heart infarction  after heat or ischemia preconditioning, respectively. Only one of these HSPA genes, Hspa12a, shows significant variability in expression levels across the brain. Hspa12a does not have a well-defined function but has been shown to be decreased in cortical regions of schizophrenic patients , and increased in atherosclerotic lesions . The classic Heat Shock Cognate 70 genes are all expressed at high levels with the exception Hspa1l, which is reported to be specifically expressed in spermatids . HSC70s have functions consistent with classical chaperones including nascent polypeptide binding, but also function in fundamental cell processes such as uncoating of clathrin-coated vesicles  and in stabilizing nascent polypeptides targeted to the translocase machinery of the mitochondrial membrane (Timm44, see below) , . Hspa8 (Hsc70) is considered to be the essential ‘housekeeping’ member of the 70 kD family which explains its high level of expression (reviewed in ).
Gene expression levels of HSPA (HSP70) family members (rows) show little variability across 17 structures (columns, see text for abbreviations) of the adult mouse brain. Hspa1a is known to be an inducible heat shock gene.
The DnaJ genes encode members of the HSP40/DnaJ family, which largely function as co-chaperones for HSPAs. The expression pattern of these genes shows considerably more variability than the chaperone genes (Figure 2). Although all 47 of the DnaJ genes analyzed in the database show some level of expression, approximately one third express at levels below the 21st percentile. The DnaJb subfamily members tend to show more consistent expression across brain regions, with several being consistently in the lower 20th percentile. DnaJb1 and 2 show substantial variation in expression levels while the DnaJb12 gene, is consistently highly expressed across all brain regions. Similar to the DnaJb family, the DnaJc family contains many genes that exhibit consistently low levels of expression. The most substantial variation in expression is exhibited by DnaJc7, 28, and 29. The two probes of DnaJc29, however, do not produce the same pattern across each brain region (for reasons unknown), but both probes indicate variable expression. The DnaJc5, 11, 18, 21, 26, and 27 family members are consistently highly expressed. Overall, there are examples of both consistency and variability in DnaJ gene expression across brain regions.
Expression levels of DnaJ (HSP40) subfamilies A, B, C, and Others (rows) are shown across 17 structures (columns) of the adult mouse brain. More than half of the genes exhibit some variability across the brain, but few have significant differences (≥2 expression quintiles in ≥2 structures). DnaJc7 (*) is also known as Ttc2, a tetratricopeptide repeat domain co-chaperone. Duplicated genes are listed where two data sets were available from the ABA (DnaJc29).
In assessing the expression of all DnaJ genes within a particular brain region, we note that the DnaJa family of chaperones is rather highly expressed in forebrain, with lower levels in other brain structures (Figure 2). Genes within the DnaJb and DnaJc families as a whole are more consistently expressed between fore-, mid-, and hindbrain with a few individual genes showing a significant degree of variability.
Other chaperones that operate in the HSPA pathway are the HSPC family members. Three of the four HSPC family members are evenly and highly expressed throughout the brain at high levels (Figure 3). HSPCs function in two major regulatory processes: 1) the heat shock response via HSF  and 2) steroid hormone receptor stabilization (reviewed in –). In the first regulatory process, HSPC forms inhibitory complexes that sequester HSF and prevent its activation of chaperone transcription. After a cellular stress, HSPCs bind misfolded proteins thus releasing their inhibition of HSF and initiating a cellular response to the stress. In the second regulatory process, HSPC binds indiscriminately to unliganded steroid hormone receptors, stabilizing them for hormone binding, and once bound, modulates gene expression. Another HSPC member, Hspc5, exhibits a more variable expression pattern, but is generally highly expressed. Hspc5 is a mitochondrial chaperone that fails to bind standard HSPC co-chaperones Ptges3 and Hop, but is classified as an HSPC due to its high homology to Hspc1 and susceptibility to geldanamycin inhibition of ATP binding and hydrolysis . Thus, the primary regulatory HSPC genes seem to be fairly uniformly expressed as might be expected. Knockout mice for Hspc4 die at 10 days of gestation from a failure of allantois to expand blood vessels once fused to the chorion .
Gene expression levels of the HSPC (HSP90) chaperone family. All are near ubiquitously and highly expressed in the adult mouse brain.
The TPR domain-containing family predominately contains proteins that exhibit prolyl-isomerase activity, and these co-chaperones are essential for the ATPase activity of HSPCs. For analysis, we divided this family into known co-chaperones with diverse homologies, FK506 binding proteins, Peptidylprolyl isomerases, and Tetratricopeptide repeat proteins (Figures 4 and 5). Like the DnaJs and their HSPA counterparts, the TPRs have a relatively higher degree of variability than their HSPC counterparts. The TPR genes in the first group that exhibit ubiquitously high expression include Nktr, Puf60, and Hop. Of these three, the most is known about Hop. Hop is a major adaptor protein which coordinates the client protein transfer from HSPA to HSPC and regulates the ATPase activity of each in the transfer process . ‘Hop’ is generally used to distinguish the mammalian version of the gene from the yeast version, stress-inducible protein 1 (STI1), whereas stress-inducible phosphoprotein 1 (Stip1) is typically the term used in proteomics literature. Hop, STI1, and Stip1 are the same gene.
Expression levels of tetratricopeptide repeat (TPR) chaperones. The TPR chaperones are divided into four subfamilies, HSPC co-chaperones (* represents proteins identified through Picard lab website; see text), FK506 binding protein (Fkbp), Peptidylprolyl isomerase (Ppi), and Tetratricopeptide repeat domain (rows). Approximately half of all TPR genes show some variability across 17 brain structures (columns). N/D indicates no data was available for those specific regions. Duplicated genes are listed where two data sets were available from the ABA.
Expression levels of tetratricopeptide repeat (TPR) chaperones. The TPR chaperones are divided into four subfamilies, HSPC co-chaperones (* represents proteins identified through Picard lab website; see text), FK506 binding protein (Fkbp), Peptidylprolyl isomerase (Ppi), and Tetratricopeptide repeat domain (rows). Approximately half of all TPR genes show some variability across 17 brain structures (columns). N/D indicates no data was available for those specific regions. Duplicated genes are listed where two data sets were available from the ABA.
Genes with high levels of variation in expression include Nudc, Ptges3, Ptplad1, and Tomm70a. Ptges3 is also thought to play a major role in protein folding by locking HSPC in an ATP-dependent state which has high affinity for client proteins . Ptplad1, which has a similar expression profile to Ptges3, has been shown to recruit Hsp90 and Fkbp8 into protein folding complexes . Tomm70a is a component of the mitochondrial translocation complex . Note that data for Tomm70a is another example in which different probes for the same gene produce discrepant data.
Within the FK506 binding protein family, approximately half are expressed below the 41st percentile. Fkbp6 and Fkbp15 are the only genes highly expressed across all brain regions. Fkbp6 forms a complex with Gapdh and Hsp90, inhibiting and down regulating Gapdh, but the function of Hsp90 in this complex has not been elucidated . Genes with variable expression levels are Fkbp1b, Fkbp5, and Fkbp16. Fkbp5 modulates the translocation of glucocorticoid receptors to the nucleus upon hormone binding ; and one might expect considerable variation in the responses of different neural cell populations to glucocorticoids.
The Peptidylprolyl isomerase (Ppi) proteins contain a cyclophilin motif, named as such due to its inhibition by the immunosuppressant cyclosporin; this small molecule-protein complex then inhibits the phosphatase calcineurin which is how cyclophilin is thought to be an immunosuppresant. This Ppi family exhibits generally low levels of expression with exceptions being Pdia1, Pdia3, Pdia6, Ppia, Ppib, and Ppic. Pdia1, Pdia3, and Pdia6 are localized to the ER. Roles for Ppi genes can be quite diverse, but Ppia and Ppib specifically have roles in HIV-host DNA integration and replication, and activation of peripheral T-lymphocytes, respectively , .
The Tetratricopeptide repeat domain is typically a 34 residue sequence, which is conserved from bacteria to humans. Proteins with this domain, like the Ppi family, have roles primarily in protein-protein interactions in diverse cellular functions. This family also has generally low levels of expression across all brain regions, but shows more variation than Ppi proteins. Genes with variable expression are Ttc10, 11, 14, 19, and 35. Ttc10 is a centrosomal protein, shown to be important for ciliogenesis and for G1-S transition in non-ciliated cells . Ttc11 has been shown to play a role in mitochondria fission, but independently activates apoptosis through the ER . Functions for Ttc14, 19, and 35 have not yet been elucidated.
HSPB (small HSPs)
Members of the HSPB family, including the crystallins, are generally expressed at low levels (Figure 6). However, Hspb5 (αB-crystallin) and Hspb7 show high levels of basal expression while µ-crystallin (crym) shows variable expression levels. Hspb7 is reported to be induced in aging skeletal muscle  while Hspb5 and µ-crystallin are predominately expressed in the mammalian lens and retina, respectively, but also in other non-CNS tissues , . Mice deficient in Hspb5 (αB-crystallin) develop normally and are viable ; however, these mice develop a skeleton muscle myopathy late in life. Whether the myopathy is due to the absence of Hspb5 is uncertain because the targeted deletion of Hspb5 also inactivates an overlapping gene, Hspb2 that is highly expressed in muscle. The nervous system of these animals appears to be normal . Hspb5 has been shown to inhibit the aggregation of mutant forms of superoxide dismutase 1 linked to familial amyotrophic lateral sclerosis , . However, mice that are deficient in Hspb5 while co-expressing mutant SOD1 show only modest changes in disease onset with no obvious change in disease course . Point mutations in other HSPBs, Hspb1 (Hspb2 in mice, Hsp27) and Hspb8 (Hsp22) cause peripheral neuropathies (reviewed in ). Dierick and colleagues discuss HSPB-mediated mechanisms other than faulty protein folding which may contribute to neuropathies, including misregulation of apoptosis and collapse of neurofilament network.
The HSPB and Crystallin genes (listed in rows) generally show low levels of expression across structures of the adult mouse brain (columns). Duplicated genes are listed where two data sets were available from the ABA (Hspb8).
HSPH (HSP100s) and AAA+ATPases
Another group of genes that encode proteins involved in the folding of client proteins are high molecular weight HSPHs and the AAA+ ATPases (Figure 7). The HSP100s have high homology to the HSPAs and have been shown to serve as their nucleotide exchange factors , . This essential activity for HSPAs might explain why all four members of the HSPHs are highly expressed across the brain.
HSPH genes (rows) are ubiquitously and highly expressed across all 17 structures of the adult mouse brain (columns). The AAA+ ATPase family members exhibit a more variable pattern. N/D indicates no data was available for those specific regions and, duplicated genes are listed where two data sets were available from the ABA.
Whether all of the AAA+ ATPase genes encode proteins that exhibit chaperone-like activity is unknown, but there are clear examples that some of these gene products are involved in the folding of specific substrates . Although almost all of the AAA+ ATPase genes that were examined are expressed at some level, approximately half of the genes are expressed at or below the 20th percentile with only six AAA+ ATPase genes showing expression at high levels across the major brain regions (Figure 7). Among the seven AAA-ATPase genes showing the greatest degree of variability are Atad1, Atad4, Psmc6, and Yme1l1. Very little is known about the Atad family, as they are named only by containing the conserved AAA+ domain. Yme1l1, a homolog of the bacterial gene Ftsh, is better known as an ATP-dependent metalloprotease. Its proteolytic activity in bacteria is documented to be involved in regulating the sigma(32) subunit of RNA polymerase, which, under stressed conditions, is mediated through interactions with DnaK and DnaJ (Hsp70 and Hsp40 homologues, respectively) . Psmc6 is one of six ATPase subunits of the 19S subcomplex – the regulatory subunit of the 26S proteasome. Given that Psmc6 serves such a housekeeping function, it is surprising to observe variation in expression levels. Another interesting gene is Tor3a which is highly expressed in the CB, but expressed at low levels (<21) in almost every other region. Tor3a is a member of the Torsin family. Mutations in the Tor1a gene (an inframe deletion of a single glutamic acid) cause early onset dystonia , . Although the function of Tor3a is unclear, it is known to be upregulated in response to interferons .
There are two chaperonin subfamilies: 1) the traditional GroEL/Hsp60/Hspd1 and GroES/Hsp10/Hspe1 partners, and 2) the Cytosolic chaperonin containing t-complex (Cct/TRiC) which function by encapsulating proteins and domains of proteins up to 220 kD in size to facilitate folding. In general, these genes are uniformly expressed across brain regions (Figure 8) and are either abundantly expressed (6 of 14 in the top 20th percentile) or poorly expressed (6 of 14 in the bottom 20th percentile); Cct subunits are not stress inducible. Among the more highly expressed are Hspd1, Hspe1, and Cct subunits 2, 4, 5, and 7. Hspd1 and Hspe1 function to refold proteins once they have been translocated to the mitochondrial matrix. Mutations in Hspd1 has been linked to hereditary spastic paraplegia 13  and a hypomyelination disorder .
Expression levels of the chaperonin and HSPD/E genes. The two major families of the chaperonin genes are the Chaperonins and Prefoldins (rows). With a few exceptions, they exhibit a bimodal expression pattern across 17 structures of the adult mouse brain (columns). N/D indicates no data was available for those specific regions.
Within the Cct subfamily, it is surprising that subunits of a heteromeric octamer are not uniformly expressed at identical levels (Figure 8). Cct substrates are primarily housekeeping cytoskeletal proteins such as actin, tubulin, and β-propeller containing proteins; however non-cytoskeletal proteins are also known to be substrates , . Not much is known about their individual function. A point mutation in Cct 4 leads to hereditary sensory neuropathy in rats  and a point mutation in Cct 5 also leads to a sensory neuropathy in humans . It has been suggested that a general inability to properly fold cytoskeletal elements in the periphery leads to neuropathies.
The Cct subfamily is aided by co-chaperones, the prefoldins. Prefoldins (Pfdn/GimC) function by binding newly synthesized, partially folded proteins from the ribosome and guiding them exclusively to the Cct complex , . Examples of variable expression levels include Prefoldins 2 and 5, but very little is known about their individual function. Humans express two additional prefoldins, Pfdn3 and Pfdn6, which are absent in mice.
The major regulators of the inducible chaperones are the Heat Shock Factors (HSFs). All of the HSFs expressed in brain are expressed at low levels (Figure 9). Interestingly, a negative regulator of HSFs, HSF-binding protein 1 (Hsbp1) , is highly expressed in all brain regions. Hsf1 is rapidly responsive to extra- or intracellular signals to activate transcription, but the response can be halted just as quickly by Hsbp1 disrupting the trimerization of Hsf1 thus preventing its binding to heat shock elements (HSEs) . Hsf1 activity is also regulated by the deacetylase SIRT1; SIRT1 removes the acetyl group from Hsf1 K80 permitting binding to the Hsp70 promoter . Knockout mice for Hsf1 are not able to induce transcription of Hsp25/27, Hsp70, or Hsp60, are of reduced size, and females are infertile . Hsf2 is known to be developmentally regulated, expressed broadly until 15.5 days of gestation, but is restricted to the CNS the rest of development. Hsf2 knockout mice have some embryonic lethality, reduced fertility, and exhibit some CNS defects , . However, these phenotypes have not been reproduced by others . While Hsf2 was shown to bind HSEs in vivo, there was no correlation to the expression of other HSPs . However, it has been suggested by in vitro studies that Hsf1 and Hsf2 coordinate the response to heat shock . Hsf4 is thought to be a negative regulator of Hsf1-mediated transcription . Mice nullizygous for Hsf4 develop cataract with abnormal lens fiber cells due to the overexpression of gamma-crystallin genes . These authors also found Hsf1 and Hsf4 compete in regulating fibroblast growth factor expression in tissue beyond the lens, regulating cell growth and differentiation. While the general heat shock response is mostly uniform across cell types, there is a trend for neurons to be more susceptible to these stressors , .
HSF proteins generally show low levels of expression whereas HSF binding protein is highly expressed. Duplicated genes are listed where two data sets were available from the ABA (Hsf1).
A number of proteins, thought to function in a chaperone pathway, do not fit precisely into previous categories and are discussed in this final group (Figure 10). Hspbp1 is one of a small group of nucleotide exchange factors for HSPA proteins that can also confer client protein specificity (reviewed in ). Hspbp1 is not inducible; it is highly expressed in the forebrain with lower levels in the cerebellum and striatum. Another gene with a similar expression pattern is Timm44, which receives proteins from Hspa8 to translocate into the mitochondria. Hspabp, thought to be a tumor suppressor, is important for Hsp70 function by mediating its interaction with Hsp90 . Hspabp and three members of HSPC are highly expressed throughout the brain but no reports were found of coordinated regulation. Overexpression of Hspabp was shown to decrease inclusion formation in an cell culture model of spinal and bulbar muscular atrophy . With additional experiments, these authors concluded this decrease was due to interactions with constitutive Hsc70 and the prevention of protein misfolding.
Expression levels are shown of genes that function within the chaperone network but do not succinctly fit in the aforementioned families are categorized as ‘Other.’
Expression by brain region
To draw further analyses regarding brain regions and levels of HSP expression, we grouped the 17 structures provided by the ABA into four major groups: forebrain, basal forebrain, midbrain, and hindbrain. We found 62 genes that exhibited high levels of expression in all five substructures of the forebrain that were analyzed (Table 3 and Figure S1). However, we found only 14 genes in which expression in the forebrain was significantly higher, or enriched, relative to all other brain regions. The specific number of genes is different for each of the four major brain groups. In the basal forebrain, midbrain, and hindbrain, we identified 38, 51, and 53 genes that were highly expressed, respectively (Figures S2, S3, S4). However, the number of genes in which there was enriched expression in these regions, relative to all other regions, was 0, 0, and 2, respectively. This finding suggests that most of the chaperones that are highly expressed in one specific region of the brain are usually expressed at ubiquitously high levels throughout the brain.
Subcellular distributions of chaperones
Heat shock proteins across all families are known to localize to specific regions within the cell. For reviews regarding chaperone activity in the cytosol, mitochondria, and ER, the reader is directed to Young et al., 2004, Voos et al., 2002, and Qiu et al., 2006 , , . Within the brain, most of the expressed genes of the chaperone network are cytosolic proteins (Table 4 and Figure S5). One well-studied functional cluster of genes involved in the folding of cytosolic proteins includes Hspa8, a variety of DnaJs, nucleotide exchange factors Bag1 and Hspbp1 (releasing Hspa8 of ADP), and Hspabp, a stabilizing factor for ADP-bound Hspa8. Hspa8 and Hspabp are both ubiquitously expressed at high levels, suggesting Hspa8 is usually stably holding client proteins in an ADP-bound state. To rapidly release client proteins, ADP is released from Hspa8 by Hspbp1 or Bag1. Hspbp1 is only highly expressed in the forebrain and Bag1 is expressed at low levels across all brain regions, suggesting that the forebrain may be more active in cytosolic chaperone activity. Additionally, the DnaJs, which activate Hspa ATP hydrolysis, are only moderately expressed in the forebrain and exhibit lower levels of expression in the other regions. By contrast, the functional cluster of chaperones in the ER is relatively uniformly expressed across different regions of the brain (either ubiquitously high or ubiquitously low).
Validation of ABA expression data
Within the existing literature, there are a number of studies that provide corroborating data to validate the expression data in the ABA. First, the ABA expression data demonstrates little or no expression for chaperones that are known to be inducible. For example, the inducible Hsp70 (Hspa1a) is present at extremely low levels in brain, whereas the constitutively expressed Hsp90, Hsc70 an Hsp60 are easily detected . Data that corroborate the inducible and constitutive expression of Hspa1a (Hsp70) and Hspa8 (Hsc70), respectively, has been shown by western blot of rat brain regions . Control or heat-shocked rat brains were dissected into cerebral cortex, hippocampus, midbrain, and spinal cord. Homogenates of each structure were analyzed by SDS-PAGE and western blots for various chaperones. Hspa8 is similarly expressed in all regions and both conditions while Hspa1a is expressed in all regions only after heat shock. The ABA scores Hspb2/Hsp27 as not expressed in any brain region (Figure 6). Immunoblot studies have demonstrated that baseline expression of Hspb2 is almost undetectable in the rat cortex, hippocampus, and midbrain . They also showed that Hspb2 is inducible, however, to detectable levels in brain. Other studies have used RT-PCR, in situ hybridization, and immunoblots across various mouse organs . In the brain, Hspb1, 5, 6, and 8 were found at the mRNA and protein level. The ABA scores all four of these genes as expressed at some level although Hsbp5 is scored as being more abundant than the other three genes (Figure 6). Hspb5 was also seen to be higher by RT-PCR analysis but not by protein . In studies of Hspb7 expression in mouse brain, RT-PCR data from Quraishe and colleagues is consistent with the ABA in that Hspb7 mRNA is detected . Note that the ABA scores expression of Hspb7 as being very high in forebrain (Figure 6). However, Quraishe reported that the protein could not be detected. Assuming that the antibody used was sensitive enough to detect the levels of protein present, this study illustrates the need to verify mRNA expression data with protein expression data. Together, these reports indicate that the ABA is consistent with the literature with regards to mRNA; however, there are instances where the ABA does not predict protein levels.
From our analysis of the chaperone expression data in ABA we can identify about 30 genes in the ABA that show a significant degree of variability in levels across different structures of the brain (Table 1, Figure 11, Table S3). Clearly it would be worthwhile to know whether the variability in mRNA levels across different brain structures translates into differing levels of protein. Most of the genes we identify as variable are poorly characterized in terms of function or protein levels. For many we could not identify validated antibody reagents that are required for accurate determination of protein levels. However, we identified antibodies for 3 genes that show a broad range of expression levels, from the lowest quintile to the highest quintile: DnaJb1, DnaJb2, and Tomm70a (Figure 11). Immunoblots of homogenates from different brain structures revealed some discrepancies between the ABA predictions based on mRNA levels and protein levels (Figure 12A). In contrast to predictions based on the ABA database, protein levels of DnaJb1 were not variable across brain structures (Figure 12B). For DnaJ2b we detected a statistically significant difference in protein levels between the cortex and the pons/medulla (Figure 12C), but ABA predicts these structures should have similar levels of expression (Figure 11). For Tomm70a the ABA contains expression data for two different probe sets, one of which predicts uniformly low levels of expression and one that predicts varied levels of expression (see Figure 4). Immunoblots for Tomm70a showed varied levels of expression with the variability closely matching what is predicted by the ABA (Figure 12D). The levels ofTomm70a were highest in striatum with statistically significant lower levels in hippocampus and pons/medulla. Thus, for 2 out of 3 of the chaperones in which we examined protein levels, we find differences from what is predicted by the ABA. It is possible that the inconsistencies between the levels of mRNA for DnaJb1 and DnaJb2 protein may be explained by subcellular localization of the proteins. The mRNA for these proteins is predominately localized to neuronal cell bodies, but these soluble cytosolic proteins are likely to be transported down axons possibly distributing the protein across many structures of the brain. In the case of Tomm70a, the protein is localized to the outer membrane of mitochondria , which are very abundant in cell bodies. From these data, it is hard to judge the extent to which the expression data in the ABA predicts protein levels in brain. It is possible that there is even less variability in the levels of chaperones across brain structures than is predicted by the ABA.
The 30 genes that are variably expressed across ≥2 brain regions are shown. Genes from all groups except HSPC and HSF are represented. Duplicated genes shown are instances where the ABA had two data sets. Generally, variably expressed genes are higher in the forebrain and lower in the rest of the brain.
A. Immunoblots of different brain regions. Top Panel – A positive control sample for the antibody was loaded in the last late (labeled DnaJ1). Quantitation for DnaJb1, DnaJb2, and Tomm70a are shown in panels B–D, respectively.
An analysis of expression data from the Allen Brain Atlas provides insight into the steady state regulation of gene expression from the chaperone network in the murine brain. About one-third of the genes of the chaperone network are expressed at low levels or not at all across the entire brain. We can be fairly confident that an absence or low levels of mRNA should be a good predictor for low levels of protein expression. However, some of these genes that are expressed at low levels in normal brain may be induced by various stimuli or disease states. The ABA predicts uniformly high levels of expression for 35 genes of the chaperone network. Whether the levels of protein for these 35 genes are uniformly high is uncertain because a myriad of post-transcriptional regulatory mechanisms could suppress translation of the mRNA or diminish the abundance of protein. However, among the 35 genes that are uniformly highly expressed are several essential house-keeping genes such as Hsc70, BiP, Hsp90, calreticulin, and calnexin. For the genes at these extremes, it is likely that the ABA provides fairly accurate predictions of protein levels.
Between these extremes are a number of genes that show variability across the structures of the brain. At the level of transcriptional regulation, we observe the greatest diversity in expression of DnaJ, TPR co-chaperones, and AAA+ATPases. This finding is not too surprising as it is thought that the products of these genes are primarily responsible for bringing protein clients to chaperone activities ; and one might expect significant diversity in regulating the folding of both unique and ubiquitous protein clients across the many diverse cell populations of the brain. However, although these expression data indicate diversity, the differences in expression levels that encode the unique signature of a neuronal population are relatively subtle. For example, between the cerebellum and cortex only 75 of the 270 genes show differences of any magnitude and of these only 6 differ in expression by values that would seem to be significant (greater than 2 quintiles in level). Of course, it is possible that post-transcriptional or post-translational regulatory processes could increase the variation in functional levels of these factors (both negatively and positively) in different neuronal populations. It is also possible that other systems involved in maintaining protein homeostasis modulate the network by regulating synthesis and degradation of some of these chaperones. Moreover, all of the chaperone network systems function as multi-protein complexes. Thus assembly of functional chaperones (particularly for the DnaJ and TPR co-chaperones) provides an opportunity to increase diversity in function. However, for each of these chaperone/co-chaperone systems, we observe relatively little variation in the expression levels of the chaperone component. For example, the DnaJ proteins that function as co-chaperones in selection of client proteins for the HSPA chaperones (HSP70s), the expression levels of the HSPA chaperones varies little (see Figure 1). A similar parallel applies to the TPR co-chaperone complexes. Thus although the formation of multiprotein complexes could produce greater diversity in function, many of the essential components of the complex are relatively uniformly expressed.
In summary, our meta-analysis organizes expression levels of mRNA for components of the chaperone network in various regions of the brain. Somewhat surprisingly, nearly a third of genes in the chaperone network are expressed at very low levels or not at all. Of the genes that are expressed, relatively few show much variation in mRNA levels across structures of the brain. Although there could be post-transcriptional mechanisms that increase variability in levels of protein for these genes, the levels of mRNA provide a view of the landscape of their regulation. As upregulation of the heat shock response gains momentum as a therapeutic intervention in neurodegenerative disease, it will be important to determine which of the genes detailed here respond to such therapeutics and whether selective modulation of subsets of chaperones might lead to disease specific interventions. Given the plethora of data provided by the ABA, it would make sense to use an in situ hybridization identical to the protocols detailed on the website as at least one approach to characterize how a specific compound or insult affects expression of the chaperone network.
Chaperones exhibiting high forebrain expression. Top portion: Genes that exhibited highest expression (red) in all five regions of the forebrain, irrespective of expression levels in other regions are compiled. Bottom portion: Genes that exhibited highest expression in 4 out of 5 forebrain regions and had fewer than three other regions with highest expression were considered to be enriched. See Table 3.
(0.24 MB TIF)
Chaperones exhibiting high basal forebrain expression. Top portion: Genes that exhibited highest expression (red) in all six regions of the basal forebrain, irrespective of expression levels in other regions are compiled. Bottom portion: No genes were found that exhibited highest expression in 5 out of 6 basal forebrain regions and had fewer than three other regions with highest expression. See Table 3.
(0.13 MB TIF)
Chaperones exhibiting high midbrain expression. Top portion: Genes that exhibited highest expression (red) in all three regions of the midbrain, irrespective of expression levels in other regions are compiled. Bottom portion: No genes were found that exhibited highest expression in 2 out of 3 midbrain regions and had fewer than four other regions with highest expression. See Table 3.
(0.17 MB TIF)
Chaperones exhibiting high hindbrain expression. Top portion: Genes that exhibited highest expression (red) in all three regions of the hindbrain, irrespective of expression levels in other regions are compiled. Bottom portion: Genes that exhibited highest expression in 2 out of 3 hindbrain regions and had fewer than four other regions with highest expression were considered to be enriched. See Table 3.
(0.18 MB TIF)
Subcellular localization of chaperones. Genes known to localize to specific subcellular compartments are organized into cytosol, endoplasmic reticulum, mitochondria, microsome, endosome, nucleus, and plasma membrane regions. N/D indicated no data was available from the ABA. (*) Serpinh1 has chaperone activity but is a member of the serpin family, of which no other members have documented chaperone activity. See Table 4.
(1.26 MB TIF)
Complete list of all chaperones identified. This table lists the full name of each gene classified herein as a chaperone. The table also lists the abbreviations used and an alias or reason the ABA was unable to provide data (ABA status), where applicable. Genes are organized into nine groups and listed alphabetically.
(0.06 MB XLS)
List of genes that are uniformly expressed across brain structures. The genes that are ubiquitously expressed at high and low levels are listed as well as genes that fail to show evidence of expression.
(0.07 MB DOC)
Hyperlinks to ABA data on 30 differentially expressed chaperones. This table lists the 30 variably expressed genes and the webpage address from the ABA. Each webpage address shows the primary data we used to compile our lists and determine the variability in expression levels.
(0.03 MB XLS)
We thank Rick Morimoto, Ron Kopito, Erich Wanker and Gill Bates for discussions relating to the design of these analyses.
Conceived and designed the experiments: ATNT DRB. Performed the experiments: ATNT DRB. Analyzed the data: ATNT DRB. Contributed reagents/materials/analysis tools: ATNT DRB. Wrote the paper: ATNT DRB.
- 1. Soto C, Estrada LD (2008) Protein misfolding and neurodegeneration. Arch Neurol 65: 184–189.
- 2. Morimoto RI, Cuervo AM (2009) Protein homeostasis and aging: taking care of proteins from the cradle to the grave. J Gerontol A Biol Sci Med Sci 64: 167–170.
- 3. Soti C, Nagy E, Giricz Z, Vigh L, Csermely P, Ferdinandy P (2005) Heat shock proteins as emerging therapeutic targets. Br J Pharmacol 146: 769–780.
- 4. Westerheide SD, Morimoto RI (2005) Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem 280: 33097–33100.
- 5. Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6: 11–22.
- 6. Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, et al. (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14: 105–111.
- 7. Qiu XB, Shao YM, Miao S, Wang L (2006) The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell Mol Life Sci 63: 2560–2570.
- 8. Ecroyd H, Carver JA (2009) Crystallin proteins and amyloid fibrils. Cell Mol Life Sci 66: 62–81.
- 9. Sun Y, MacRae TH (2005) Small heat shock proteins: molecular structure and chaperone function. Cell Mol Life Sci 62: 2460–2476.
- 10. Hanson PI, Whiteheart SW (2005) AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol 6: 519–529.
- 11. Spiess C, Meyer AS, Reissmann S, Frydman J (2004) Mechanism of the eukaryotic chaperonin: protein folding in the chamber of secrets. Trends Cell Biol 14: 598–604.
- 12. Braak H, Braak E, Bohl J, Bratzke H (1998) Evolution of Alzheimer's disease related cortical lesions. J Neural Transm Suppl :5497–106. 97–106.
- 13. Sharp AH, Loev SJ, Schilling G, Li SH, Li XJ, et al. (1995) Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14: 1065–1074.
- 14. Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, et al. (1998) Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis 4: 387–397.
- 15. Morimoto RI (2008) Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev 22: 1427–1438.
- 16. Yoshihara T, Ishigaki S, Yamamoto M, Liang Y, Niwa J, et al. (2002) Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 80: 158–167.
- 17. Luthi-Carter R, Strand AD, Hanson SA, Kooperberg C, Schilling G, et al. (2002) Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum Mol Genet 11: 1927–1937.
- 18. Desplats PA, Kass KE, Gilmartin T, Stanwood GD, Woodward EL, et al. (2006) Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. J Neurochem 96: 743–757.
- 19. Crocker SF, Costain WJ, Robertson HA (2006) DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations. Brain Res 1088: 176–186.
- 20. Fukada Y, Yasui K, Kitayama M, Doi K, Nakano T, et al. (2007) Gene expression analysis of the murine model of amyotrophic lateral sclerosis: studies of the Leu126delTT mutation in SOD1. Brain Res 1160: 1–10.
- 21. Ferraiuolo L, Heath PR, Holden H, Kasher P, Kirby J, Shaw PJ (2007) Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J Neurosci 27: 9201–9219.
- 22. Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, et al. (2007) Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16: 1845–1861.
- 23. Becanovic K, Pouladi MA, Lim RS, Kuhn A, Pavlidis P, et al. (2010) Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. Hum Mol Genet. In press.
- 24. Ginsberg SD, Hemby SE, Lee VM, Eberwine JH, Trojanowski JQ (2000) Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 48: 77–87.
- 25. Mirnics K, Norstrom EM, Garbett K, Choi SH, et al. (2008) Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice. Mol Neurodegener 3: 14:14.
- 26. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, et al. (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445: 168–176.
- 27. Blatch GL, Lassle M (1999) The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. Bioessays 21: 932–939.
- 28. Lee SH, Kim M, Yoon BW, Kim YJ, Ma SJ, et al. (2001) Targeted hsp70.1 disruption increases infarction volume after focal cerebral ischemia in mice. Stroke 32: 2905–2912.
- 29. Van MW, Wielockx B, Mahieu T, Takada M, Taniguchi T, et al. (2002) HSP70 protects against TNF-induced lethal inflammatory shock. Immunity 16: 685–695.
- 30. Hampton CR, Shimamoto A, Rothnie CL, Griscavage-Ennis J, Chong A, et al. (2003) HSP70.1 and -70.3 are required for late-phase protection induced by ischemic preconditioning of mouse hearts. Am J Physiol Heart Circ Physiol 285: H866–H874.
- 31. Pongrac JL, Middleton FA, Peng L, Lewis DA, Levitt P, et al. (2004) Heat shock protein 12A shows reduced expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry 56: 943–950.
- 32. Han Z, Truong QA, Park S, Breslow JL (2003) Two Hsp70 family members expressed in atherosclerotic lesions. Proc Natl Acad Sci U S A 100: 1256–1261.
- 33. Matsumoto M, Fujimoto H (1990) Cloning of a hsp70-related gene expressed in mouse spermatids. Biochem Biophys Res Commun 166: 43–49.
- 34. Tavaria M, Gabriele T, Anderson RL, Mirault ME, Baker E, et al. (1995) Localization of the gene encoding the human heat shock cognate protein, HSP73, to chromosome 11. Genomics 29: 266–268.
- 35. Deshaies RJ, Koch BD, Werner-Washburne M, Craig EA, Schekman R (1988) A subfamily of stress proteins facilitates translocation of secretory and mitochondrial precursor polypeptides. Nature 332: 800–805.
- 36. Terada K, Ohtsuka K, Imamoto N, Yoneda Y, Mori M (1995) Role of heat shock cognate 70 protein in import of ornithine transcarbamylase precursor into mammalian mitochondria. Mol Cell Biol 15: 3708–3713.
- 37. Vos MJ, Hageman J, Carra S, Kampinga HH (2008) Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 47: 7001–7011.
- 38. Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R (1998) Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94: 471–480.
- 39. Voellmy R, Boellmann F (2007) Chaperone regulation of the heat shock protein response. Adv Exp Med Biol: 594: 89–99. 89–99.
- 40. Picard D (2006) Chaperoning steroid hormone action. Trends Endocrinol Metab 17: 229–235.
- 41. Smith DF, Toft DO (2008) Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions. Mol Endocrinol 22: 2229–2240.
- 42. Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO (2000) The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 275: 3305–3312.
- 43. Voss AK, Thomas T, Gruss P (2000) Mice lacking HSP90beta fail to develop a placental labyrinth. Development 127: 1–11.
- 44. Song Y, Masison DC (2005) Independent regulation of Hsp70 and Hsp90 chaperones by Hsp70/Hsp90-organizing protein Sti1 (Hop1). J Biol Chem 280: 34178–34185.
- 45. McLaughlin SH, Sobott F, Yao ZP, Zhang W, Nielsen PR, et al. (2006) The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J Mol Biol 356: 746–758.
- 46. Taguwa S, Okamoto T, Abe T, Mori Y, Suzuki T, et al. (2008) Human butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replication. J Virol 82: 2631–2641.
- 47. Young JC, Hoogenraad NJ, Hartl FU (2003) Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell 112: 41–50.
- 48. Jarczowski F, Jahreis G, Erdmann F, Schierhorn A, Fischer G, et al. (2009) FKBP36 is an inherent multifunctional glyceraldehyde-3-phosphate dehydrogenase inhibitor. J Biol Chem 284: 766–773.
- 49. Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, et al. (2005) FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 280: 4609–4616.
- 50. Hatziioannou T, Perez-Caballero D, Cowan S, Bieniasz PD (2005) Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J Virol 79: 176–183.
- 51. Carpentier M, Allain F, Slomianny MC, Durieux S, Vanpouille C, et al. (2002) Receptor type I and type II binding regions and the peptidyl-prolyl isomerase site of cyclophilin B are required for enhancement of T-lymphocyte adhesion to fibronectin. Biochemistry 41: 5222–5229.
- 52. Robert A, Margall-Ducos G, Guidotti JE, Bregerie O, Celati C, et al. (2007) The intraflagellar transport component IFT88/polaris is a centrosomal protein regulating G1-S transition in non-ciliated cells. J Cell Sci 120: 628–637.
- 53. Alirol E, James D, Huber D, Marchetto A, Vergani L, et al. (2006) The mitochondrial fission protein hFis1 requires the endoplasmic reticulum gateway to induce apoptosis. Mol Biol Cell 17: 4593–4605.
- 54. Doran P, Gannon J, O'Connell K, Ohlendieck K (2007) Aging skeletal muscle shows a drastic increase in the small heat shock proteins alphaB-crystallin/HspB5 and cvHsp/HspB7. Eur J Cell Biol 86: 629–640.
- 55. Dubin RA, Wawrousek EF, Piatigorsky J (1989) Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol Cell Biol 9: 1083–1091.
- 56. Kim RY, Gasser R, Wistow GJ (1992) mu-crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. Proc Natl Acad Sci U S A 89: 9292–9296.
- 57. Brady JP, Garland DL, Green DE, Tamm ER, Giblin FJ, et al. (2001) AlphaB-crystallin in lens development and muscle integrity: a gene knockout approach. Invest Ophthalmol Vis Sci 42: 2924–2934.
- 58. Wang J, Xu G, Li H, Gonzales V, Fromholt D, et al. (2005) Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: alphaB-crystallin modulates aggregation. Hum Mol Genet 14: 2335–2347.
- 59. Karch CM, Borchelt DR (2010) An examination of alphaB-crystallin as a modifier of SOD1 aggregate pathology and toxicity in models of familial amyotrophic lateral sclerosis. J Neurochem 5: 1092–100.
- 60. Dierick I, Irobi J, De JP, Timmerman V (2005) Small heat shock proteins in inherited peripheral neuropathies. Ann Med 37: 413–422.
- 61. Dragovic Z, Broadley SA, Shomura Y, Bracher A, Hartl FU (2006) Molecular chaperones of the Hsp110 family act as nucleotide exchange factors of Hsp70s. EMBO J 25: 2519–2528.
- 62. Raviol H, Sadlish H, Rodriguez F, Mayer MP, Bukau B (2006) Chaperone network in the yeast cytosol: Hsp110 is revealed as an Hsp70 nucleotide exchange factor. EMBO J 25: 2510–2518.
- 63. Rodriguez F, rsene-Ploetze F, Rist W, Rudiger S, Schneider-Mergener J, et al. (2008) Molecular basis for regulation of the heat shock transcription factor sigma32 by the DnaK and DnaJ chaperones. Mol Cell 32: 347–358.
- 64. Slominsky PA, Markova ED, Shadrina MI, Illarioshkin SN, Miklina NI, et al. (1999) A common 3-bp deletion in the DYT1 gene in Russian families with early-onset torsion dystonia. Hum Mutat 19: 14:269.
- 65. Ozelius LJ, Page CE, Klein C, Hewett JW, Mineta M, et al. (1999) The TOR1A (DYT1) gene family and its role in early onset torsion dystonia. Genomics 62: 377–384.
- 66. Dron M, Meritet JF, ndoy-Dron F, Meyniel JP, Maury C, et al. (2002) Molecular cloning of ADIR, a novel interferon responsive gene encoding a protein related to the torsins. Genomics 79: 315–325.
- 67. Hansen JJ, Durr A, Cournu-Rebeix I, Georgopoulos C, Ang D, et al. (2002) Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet 70: 1328–1332.
- 68. Magen D, Georgopoulos C, Bross P, Ang D, Segev Y, et al. (2008) Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet 83: 30–42.
- 69. Horwich AL, Fenton WA, Chapman E, Farr GW (2007) Two families of chaperonin: physiology and mechanism. Annu Rev Cell Dev Biol : 23: 115–45. 115–145.
- 70. Lee MJ, Stephenson DA, Groves MJ, Sweeney MG, Davis MB, et al. (2003) Hereditary sensory neuropathy is caused by a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct4) gene. Hum Mol Genet 12: 1917–1925.
- 71. Bouhouche A, Benomar A, Bouslam N, Chkili T, Yahyaoui M (2006) Mutation in the epsilon subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct5) gene causes autosomal recessive mutilating sensory neuropathy with spastic paraplegia. J Med Genet 43: 441–443.
- 72. Vainberg IE, Lewis SA, Rommelaere H, Ampe C, Vandekerckhove J, et al. (1998) Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell 93: 863–873.
- 73. Martin-Benito J, Boskovic J, Gomez-Puertas P, Carrascosa JL, Simons CT, et al. (2002) Structure of eukaryotic prefoldin and of its complexes with unfolded actin and the cytosolic chaperonin CCT. EMBO J 21: 6377–6386.
- 74. Satyal SH, Chen D, Fox SG, Kramer JM, Morimoto RI (1998) Negative regulation of the heat shock transcriptional response by HSBP1. Genes Dev 12: 1962–1974.
- 75. Cotto JJ, Morimoto RI (1999) Stress-induced activation of the heat-shock response: cell and molecular biology of heat-shock factors. Biochem Soc Symp : 64: 105–18. 105–118.
- 76. Westerheide SD, Anckar J, Stevens SM Jr, Sistonen L, Morimoto RI (2009) Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 323: 1063–1066.
- 77. McMillan DR, Xiao X, Shao L, Graves K, Benjamin IJ (1998) Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J Biol Chem 273: 7523–7528.
- 78. Kallio M, Chang Y, Manuel M, Alastalo TP, Rallu M, et al. (2002) Brain abnormalities, defective meiotic chromosome synapsis and female subfertility in HSF2 null mice. EMBO J 21: 2591–2601.
- 79. Wang G, Zhang J, Moskophidis D, Mivechi NF (2003) Targeted disruption of the heat shock transcription factor (hsf)-2 gene results in increased embryonic lethality, neuronal defects, and reduced spermatogenesis. Genesis 36: 48–61.
- 80. McMillan DR, Christians E, Forster M, Xiao X, Connell P, et al. (2002) Heat shock transcription factor 2 is not essential for embryonic development, fertility, or adult cognitive and psychomotor function in mice. Mol Cell Biol 22: 8005–8014.
- 81. Rallu M, Loones M, Lallemand Y, Morimoto R, et al. (1997) Function and regulation of heat shock factor 2 during mouse embryogenesis. Proc Natl Acad Sci U S A 94: 2392–2397.
- 82. Ostling P, Bjork JK, Roos-Mattjus P, Mezger V, Sistonen L (2007) Heat shock factor 2 (HSF2) contributes to inducible expression of hsp genes through interplay with HSF1. J Biol Chem 282: 7077–7086.
- 83. Zhang Y, Frejtag W, Dai R, Mivechi NF (2001) Heat shock factor-4 (HSF-4a) is a repressor of HSF-1 mediated transcription. J Cell Biochem 82: 692–703.
- 84. Fujimoto M, Izu H, Seki K, Fukuda K, Nishida T, et al. (2004) HSF4 is required for normal cell growth and differentiation during mouse lens development. EMBO J 23: 4297–4306.
- 85. Soti C, Csermely P (2002) Chaperones and aging: role in neurodegeneration and in other civilizational diseases. Neurochem Int 41: 383–389.
- 86. Pratt WB, Toft DO (2003) Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228: 111–133.
- 87. Howarth JL, Glover CP, Uney JB (2009) HSP70 interacting protein prevents the accumulation of inclusions in polyglutamine disease. J Neurochem 108: 945–951.
- 88. Young JC, Agashe VR, Siegers K, Hartl FU (2004) Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 5: 781–791.
- 89. Voos W, Rottgers K (2002) Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim Biophys Acta 1592: 51–62.
- 90. D'Souza SM, Brown IR (1998) Constitutive expression of heat shock proteins Hsp90, Hsc70, Hsp70, and Hsp60 in neural and non-neural tissues of the rat during postnatal development. Cell Stress Chaperones 3: 188–99.
- 91. Chen S, Brown IR (2007) Neuronal expression of constitutive heat shock proteins: implications for neurodegenerative diseases. Cell Stress Chaperones 12: 51–58.
- 92. Quraishe S, Asuni A, Boelens WC, O'Connor V, Wyttenbach A (2008) Expression of the small heat shock protein family in the mouse CNS: differential anatomical and biochemical compartmentalization. Neuroscience 153: 483–491.
- 93. Hennessy F, Nicoll WS, Zimmermann R, Cheetham ME, Blatch GL (2005) Not all J domains are created equal: implications for the specificity of Hsp40-Hsp70 interactions. Protein Sci 14: 1697–1709.